Auro Labs.

Sell

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE292C01011
NSEID:
BSEID: 530233

INR

235.00

-18 (-7.11%)

BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 2.08 k

Click here to access the older version

Cash Flow

Auro Labs. Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Compare Cash Flow Results of Auro Labs.

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

10.35

2259.57

-2,249.00

-99.54%

Adjustment

2.08

161.91

-159.00

-98.72%

Changes In working Capital

6.38

-40.95

46.00

115.58%

Cash Flow after changes in Working Capital

18.81

2380.53

-2,362.00

-99.21%

Cash Flow from Operating Activities

18.81

1982.97

-1,964.00

-99.05%

Cash Flow from Investing Activities

-38.67

-1919.22

1,881.00

97.99%

Cash Flow from Financing Activities

19.09

-8.68

27.00

319.93%

Net Cash Inflow / Outflow

-0.77

55.07

-55.00

-101.40%

Opening Cash & Cash Equivalents

2.42

134.13

-132.00

-98.20%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

1.65

189.2

-188.00

-99.13%

Cash Flow - Snapshot (Standalone) - Mar'24

YoY Growth in year ended Mar 2024 is 473.48% vs 149.77% in Mar 2023

Mar'24

Mar'23

Change(%)

Cash Flow from Operating Activities

18.81

3.28

473.48%